XML 49 R31.htm IDEA: XBRL DOCUMENT v3.25.1
Stock Incentive Plan (Tables)
 12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Disclosure of Share-based Compensation Arrangements
The Company recorded share-based compensation expense as follows for the years ended December 31, 2024, 2023 and 2022:

Year Ended
December 31,
2024		December 31,
2023		December 31,
2022
Salaries, wages and employee benefits - continuing operations$9,120 $10,090 $9,196 
Salaries, wages and employee benefits - discontinued operation— 504 706 
Total share-based compensation expense$9,120 $10,594 $9,902 
Schedule of Weighted Average Assumptions
The weighted average grant-date fair value of the stock option awards granted under the Omnibus Plan and the weighted average assumptions under the Black-Scholes option-pricing model were as follows for the years ended December 31, 2024, 2023 and 2022.
December 31, 2024December 31, 2023December 31, 2022
Weighted average grant-date fair value$— $39.75 $28.91 
Weighted average assumptions under Black-Scholes option model:
Expected dividend yield— %0.8 %0.9 %
Expected stock price volatility— %32.5 %28.7 %
Risk-free interest rate— %3.8 %1.9 %
Expected life of awards (years)05.65.6
Schedule of Stock Option Activity
Stock option transactions during the year ended December 31, 2024 on a continuing operations basis were as follows:
Number of Shares Weighted Average Exercise Price
Outstanding as of January 1$370 $76.83 
Granted— — 
Exercised— — 
Forfeited or Canceled(90)76.06 
Outstanding as of December 31$280 $77.08 
The following table sets forth the exercise price range, number of shares, weighted average exercise price and remaining contractual lives by groups of similar price on a continuing operations basis as of December 31, 2024:

Stock Options OutstandingStock Options Exercisable
Range of Exercise PricesNumber of SharesWeighted Average Remaining Contractual Life (in years)Weighted Average Exercise Price
Exercisable as of December 31, 2024
Weighted Average Exercise Price
$58.40 -$59.89 33 0.1$58.54 33 $58.54 
$64.26 -$75.05 175 1.567.02 175 67.02 
100.93 -115.42 72 4.5109.75 61 109.43 
280 $77.08 269 $75.68 
Schedule of Restricted Share Activity
Restricted share transactions on a continuing operations basis for the year ended December 31, 2024 were as follows:
Number of Shares Weighted Average Grant Date Fair Value
Outstanding as of January 1133 $104.87 
Granted481 30.66 
Vested(115)71.15 
Forfeited(117)48.70 
Outstanding as of December 31382 $38.78 
Director restricted share transactions for the year ended December 31, 2024 were as follows:
Number of Shares Weighted Average Grant Date Fair Value
Outstanding as of January 114 $96.10 
Granted26 23.58 
Vested(22)71.79 
Forfeited— — 
Outstanding as of December 3118 $18.67 

Year Ended
December 31,
2024		December 31,
2023		December 31,
2022
Share-based compensation expense for restricted shares$984 $1,329 $1,387 
Schedule of Nonvested Performance-based Units Activity The weighted average grant-date fair value of performance awards granted under the Omnibus Plan and the weighted average assumptions under the Monte Carlo simulation model were as follows for the years ended December 31, 2024, 2023 and 2022:
Year Ended
December 31, 2024December 31, 2023December 31, 2022
Weighted average grant-date fair value$11.87 $120.27 $127.29 
Weighted average assumptions under the Monte Carlo simulation model:
Expected stock price volatility42.8 %37.8 %35.5 %
Weighted average risk-free interest rate4.7 %4.2 %1.6 %
Schedule of Performance Award Transactions
Performance award transactions for the year ended December 31, 2024 on a continuing operations basis were as follows assuming target levels of performance:
Number of Shares Weighted Average Grant Date Fair Value
Outstanding as of January 161 $105.88 
Granted416 11.87 
Additional shares awarded based on actual performance level achieved14 92.89 
Earned(39)88.01 
Forfeited or unearned (113)33.34 
Outstanding as of December 31339 $15.88 
Schedule of Employee Stock Purchase Plan
Employee stock purchase plan activity and related information was as follows on a continuing operations basis:
Year Ended
December 31, 2024December 31, 2023December 31, 2022
Shares purchased by participants under the ESPP44 10 8 
Average purchase price$17.16 $69.81 $82.48 
Weighted average fair value of each purchase under the ESPP granted1
$1.91 $7.76 $9.17 
Share-based compensation expense for ESPP$84 $76 $78 
1 Equal to the discount from the market value of the common stock at the end of each six month purchase period.